Gut bacteria vs. weight loss drug: which works better?
NCT ID NCT06989177
First seen Mar 20, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This study looks at whether a probiotic called Lactobacillus paracasei LC-19 can help overweight or obese adults lose weight and improve their metabolism. Researchers will compare it to a weight-loss drug (semaglutide) and a placebo over 12 weeks, while all participants follow a reduced-calorie diet and lifestyle plan. The goal is to find safer, more personalized ways to manage weight and prevent weight regain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences
RECRUITINGHangzhou, Zhejiang, 310024, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.